What is the average price target for ALTIMMUNE INC (ALT) stock?
15 analysts have analysed ALT and the average price target is 19.58 USD. This implies a price increase of 495.26% is expected in the next year compared to the current price of 3.29.
ALTIMMUNE INC (ALT) Forecast, Price Target & Analyst Ratings
NASDAQ:ALT • US02155H2004
Current stock price
3.29 USD
+0.06 (+1.86%)
At close:
3.29 USD
0 (0%)
Pre-Market:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALTIMMUNE INC (ALT).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.25
- Revenue Estimate
- 717.1
Price Target Details & History
Consensus Price Target and Range
Mean target
$19.58
Upside
+ 495.26%
From current price of $3.29 to mean target of $19.58, Based on 15 analyst forecasts
Low
$1.01
Median
$21.42
High
$29.40
Price Target Revisions
1 Month
4.92%
3 Months
4.10%
Price Target Summary
15 Wall Street analysts provided a forecast for the next 12 months for ALT. The average price target is 19.58 USD. This implies a price increase of 495.26% is expected in the next year compared to the current price of 3.29.
The average price target has been revised upward by 4.1% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
78.67%
ALT was analyzed by 15 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about ALT.
In the previous month the buy percentage consensus was at a similar level.
ALT was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-03-06 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-11-07 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-10-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-10-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-13 | UBS | Maintains | Buy -> Buy |
| 2025-08-13 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-10 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-06-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-02 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-14 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-28 | William Blair | Initiate | Market Perform |
| 2025-02-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-08 | Stifel | Initiate | Buy |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-12 | UBS | Initiate | Buy |
| 2024-08-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2024-06-25 | B. Riley Securities | Reiterate | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.25
- Revenue Estimate
- 717.1
- Revenue Q2Q
- -85.66%
- EPS Q2Q
- 4.91%
- Number of Analysts
- 10
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-29.00%
EPS (1 Month)
1.78%
EPS (3 Months)
7.28%
Next Earnings Summary
ALT is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -0.25 USD and the consensus revenue estimate is 717.1 USD.
The next earnings revenue estimate has been revised downward by 29% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 426K 708.57% | 20K -95.31% | 41K 105.00% | 5.181K -87.36% | -100.00% | 118.21M | 479.55M 305.68% | 724.68M 51.12% | 1.054B 45.44% | 1.509B 43.17% | 1.956B 29.62% | |
| EBITDA YoY % growth | -83.033M 7.95% | -102.934M -23.97% | -94.377M 8.31% | -135.789M -43.88% | -165.117M -21.60% | -179.064M -8.45% | -9.635M 94.62% | 109.49M 1,236.39% | 160.52M 46.61% | 315.43M 96.51% | 525.66M 66.65% | |
| EBIT YoY % growth | -83.51M 4.82% | -103.172M -23.54% | -94.489M 8.42% | -137.614M -45.64% | -173.698M -26.22% | -107.145M 38.32% | 269.21M 351.26% | 426.61M 58.47% | 672.16M 57.56% | 1.058B 57.40% | 1.463B 38.28% | |
| Operating Margin | -19,603.29% | -515,860.00% | -230,460.98% | -2,655,972.32% | N/A | -90.64% | 56.14% | 58.87% | 63.77% | 70.11% | 74.80% | |
| EPS YoY % growth | -1.44 18.64% | -1.34 6.94% | -1.01 24.63% | -1.14 -12.89% | -1.27 -11.42% | -0.62 51.10% | 4.05 751.50% | 6.08 50.33% | 20.19 231.88% | 22.99 13.86% | 25.66 11.64% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.25 4.91% | -0.25 5.57% | -0.29 -36.70% | -0.32 -19.24% | -0.34 -36.86% | -0.35 -38.65% | -0.37 -28.42% | -0.35 -9.02% | -0.37 -10.45% | -0.37 -5.71% | -0.37 -1.37% | -0.36 -3.60% |
| Revenue Q2Q % growth | 717.1 -85.66% | 717.1 -85.66% | 717.1 -85.66% | -100.00% | -100.00% | -100.00% | -100.00% | N/A | N/A | N/A | N/A | |
| EBITDA Q2Q % growth | -28.718M -31.82% | -31.114M -36.09% | -38.147M -83.64% | -31.613M -9.84% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -29.27M -34.17% | -31.852M -38.96% | -36.335M -74.19% | -39.454M -36.55% | -35.063M -19.79% | -37.41M -17.45% | -39.323M -8.22% | -41.392M -4.91% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
11.47%
EPS Next 5 Year
51.66%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
2,124.67%
Revenue Next 5 Year
824.40%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-25.25%
EBIT Next 5 Year
26.20%
ALTIMMUNE INC / ALT Forecast FAQ
What is the next earnings date for ALT stock?
ALTIMMUNE INC (ALT) will report earnings on 2026-05-07, before the market open.
What are the consensus estimates for ALT stock next earnings?
The consensus EPS estimate for the next earnings of ALTIMMUNE INC (ALT) is -0.25 USD and the consensus revenue estimate is 717.1 USD.
Can you provide the expected long term growth rate for ALTIMMUNE INC stock?
The expected long term growth rate for ALTIMMUNE INC (ALT) is 2124.67%.